ALK-4290 Uses, Dosage, Side Effects and more
ALK-4290 is under investigation in clinical trial NCT03558061 (Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration).
| Trade Name | ALK-4290 |
| Generic | ALK-4290 |
| Type | |
| Formula | C27H34ClN5O3 |
| Weight | Average: 512.05 Monoisotopic: 511.2350177 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
